Further insights into the effects of pre-organizing the BimBH3 Helix

ACS Chemical Biology

Volumn 9, Issue 3, 2014, Pages 838-839

  Okamoto, Toru ^a,b   Segal, David ^a,b   Zobel, Kerry ^c   Fedorova, Anna ^c   Yang, Hong ^a,b   Fairbrother, Wayne J ^c   Huang, David C S ^a,b   Smith, Brian J ^d   Deshayes, Kurt ^c   Czabotar, Peter E ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c GENENTECH INC   (United States)

^d LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIMBH3 HELIX PEPTIDE; LYSINE; PEPTIDE; PROTEIN BCL XL; PROTEIN MCL 1; UNCLASSIFIED DRUG; ONCOPROTEIN; PEPTIDE FRAGMENT;

BINDING ASSAY; BIOASSAY; CANCER CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; COLON CANCER; LETTER; LIMIT OF DETECTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RING CLOSING METATHESIS; WILD TYPE; ANIMAL; APOPTOSIS; CHEMISTRY; HUMAN; METABOLISM;

ANIMALS; APOPTOSIS; HUMANS; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS;

EID: 84896977041     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb400638p     Document Type: Letter

References (6)

1. Okamoto, T., Zobel, K., Fedorova, A., Quan, C., and Yang, H. 2013, Stabilizing the pro-apoptotic BimBH3 helix (BimSAHB) does not necessarily enhance affinity or biological activity ACS Chem. Biol. 8, 297-302
2. Gavathiotis, E., Suzuki, M., Davis, M. L., Pitter, K., and Bird, G. H. 2008, BAX activation is initiated at a novel interaction site Nature 455, 1076-1081
3. Bird, G. H., Gavathiotis, E., LaBelle, J. L., Katz, S. G., and Walensky, L. D. (2013) Distinct BimBH3 (BimSAHB) stapled peptides for structural and cellular studies ACS Chem. Biol. 10.1021/cb4003305
4. LaBelle, J. L., Katz, S. G., Bird, G. H., Gavathiotis, E., and Stewart, M. L. 2012, A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers J. Clin. Invest. 122, 2018-2031
5. Giordanetto, F., Revell, J. D., Knerr, L., Hostettler, M., and Paunovic, A. 2013, Stapled vasoactive intestinal peptide (VIP) derivatives improve VPAC2 agonism and glucose-dependent insulin secretion ACS Med. Chem. Lett. 4, 1163-1168
6. Peng, R., Tong, J. S., Li, H., Yue, B., and Zou, F. 2013, Targeting Bax interaction sites reveals that only homo-oligomerization sites are essential for its activation Cell Death Differ. 20, 744-754